Skip to main content

AusPAR: Ustekinumab

Australian Public Assessment Report
Device/Product Name
Stelara
Active ingredients
Ustekinumab
AusPAR Date
Published
Submission Number
PM-2013-04148-1-3
Submission Type
Extension of indications
Decision
Approved

Help us improve the Therapeutic Goods Administration site